BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35867500)

  • 1. Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United States.
    Wong RJ; Kaufman HW; Niles JK; Meyer WA; Chitnis AS
    J Public Health Manag Pract; 2022 Sep-Oct 01; 28(5):452-462. PubMed ID: 35867500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States.
    Wong RJ; Rupp L; Lu M; Yang Z; Daida YG; Schmidt M; Boscarino JA; Gordon SC; Chitnis AS
    J Viral Hepat; 2023 Jun; 30(6):512-519. PubMed ID: 36843435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection.
    Liu S; He Z; Wu W; Jin H; Cui Y
    Clin Rheumatol; 2023 Sep; 42(9):2369-2376. PubMed ID: 37219751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis.
    Chou C; Veracruz N; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 Dec; 29(12):1107-1114. PubMed ID: 36138556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis and Hepatitis B Virus in an Integrated Healthcare System - California, 2008-2019.
    Malden DE; Wong RJ; Chitnis AS; Im TM; Tartof SY
    Am J Med; 2024 Mar; 137(3):258-265.e3. PubMed ID: 38000687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis.
    Chen J; Hubbard A; Bagley L; Shiau R; Wong RJ; Chitnis AS
    Dig Dis Sci; 2022 Jun; 67(6):2646-2654. PubMed ID: 34056681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B surface antigen and hepatitis B core antibody among adults with latent tuberculosis infection.
    Hubbard A; Hirode G; Chitnis A; Wong R
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e610-e614. PubMed ID: 35048652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn's Disease on Ustekinumab: A Nationwide Real-World Study.
    Liu R; Li Z; Ye L; Hu J; Tang J; Chen B; Chen X; Tan B; Gu Y; Xie C; Ouyang C; Song X; Li F; Fan Y; Ren H; Zhu L; Chen M; Jiang W; Cao Q
    Inflamm Bowel Dis; 2024 Jan; 30(1):45-52. PubMed ID: 36880432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Tyson GL; Kramer JR; Duan Z; Davila JA; Richardson PA; El-Serag HB
    Hepatology; 2013 Aug; 58(2):538-45. PubMed ID: 23505059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
    Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
    BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
    Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
    World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis.
    Wong RJ; Hubbard A; Bagley L; Shiau R; Chitnis AS
    J Clin Gastroenterol; 2022 Aug; 56(7):601-617. PubMed ID: 34009841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
    Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
    PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa.
    Msomi N; Naidoo K; Yende-Zuma N; Padayatchi N; Govender K; Singh JA; Abdool-Karim S; Abdool-Karim Q; Mlisana K
    BMC Infect Dis; 2020 Nov; 20(1):847. PubMed ID: 33198649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies.
    Zheng J; Guo MH; Peng HW; Cai XL; Wu YL; Peng XE
    Epidemiol Infect; 2020 Nov; 148():e290. PubMed ID: 33222713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.
    Spradling PR; Richardson JT; Buchacz K; Moorman AC; Brooks JT;
    J Viral Hepat; 2010 Dec; 17(12):879-86. PubMed ID: 20158604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil.
    Iglecias LM; Puga MA; Pompílio MA; Teles SA; Croda J; Lima LA; Lago BV; Martins RM; Motta-Castro AR
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1509-1515. PubMed ID: 27776593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Latent Tuberculosis Infection Among Non-US-Born Persons by Country of Birth-United States, 2012-2017.
    Collins JM; Stout JE; Ayers T; Hill AN; Katz DJ; Ho CS; Blumberg HM; Winglee K;
    Clin Infect Dis; 2021 Nov; 73(9):e3468-e3475. PubMed ID: 33137172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chronic viral hepatitis on tuberculosis treatment interruption.
    Chua AP; Lim LK; Gan SH; Chee CB; Wang YT
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1486-1494. PubMed ID: 30606322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.